Overview
Corneal Collagen Cross-Linking (often abbreviated as CXL or KXL) is a highly effective, minimally invasive therapeutic procedure designed specifically to halt the progression of keratoconus and other corneal ectatic disorders. Keratoconus is a progressive condition where the cornea—the clear front surface of the eye—gradually thins and bulges outward into a cone shape. This structural weakness leads to distorted, blurred vision that becomes increasingly difficult to correct with standard glasses or contact lenses.
Mr Arthur Okonkwo, a dual fellowship-trained Consultant Ophthalmologist based in Leeds, offers comprehensive assessment and expert delivery of Corneal Collagen Cross-Linking. The primary goal of this procedure is not to reverse existing damage or necessarily improve current vision, but rather to significantly strengthen the corneal tissue to prevent the condition from worsening. By intervening early, CXL can successfully save patients from requiring a complex corneal transplant later in life.
The procedure utilises a combination of specially formulated riboflavin (Vitamin B2) eye drops and targeted ultraviolet-A (UV-A) light. When the UV-A light activates the riboflavin within the cornea, it creates new chemical bonds—or “cross-links”—between the collagen fibres that make up the corneal structure. This process acts like adding scaffolding to a weakened building, significantly increasing the biomechanical strength and rigidity of the cornea, thereby arresting further bulging and thinning.
Key Benefits
- Halts disease progression
- Prevents corneal transplantation
- Strengthens corneal tissue
- Minimally invasive
- Maintains contact lens tolerance
- Expert Consultant care
Conditions Treated
- Progressive Keratoconus
- Pellucid Marginal Degeneration (PMD)
- Post-LASIK Ectasia
- Corneal Thinning Disorders
What to Expect
1
Initial Consultation
A detailed discussion of your visual symptoms and medical history.
2
Diagnostic Assessment
Comprehensive corneal topography and advanced optical coherence tomography (OCT) scans are performed.
3
Treatment Preparation
The procedure is performed as a day case under local anaesthetic eye drops.
4
The Procedure
Specially formulated riboflavin (Vitamin B2) drops are applied to the eye for approximately 10 to 30 minutes.
5
Immediate Aftercare
Following the procedure, a clear, protective "bandage" contact lens is placed on the eye to promote healing and improve comfort.
6
Follow-Up Care
Thorough post-operative instructions are provided, including a strict schedule for antibiotic and anti-inflammatory eye drops.
Frequently Asked Questions
Will Corneal Collagen Cross-Linking improve my vision?
The primary goal of CXL is not to improve your vision, but rather to strengthen the cornea and stop keratoconus from getting worse. While a small percentage of patients may experience a slight improvement in their visual acuity or a reduction in astigmatism months after the procedure, you should expect your vision to remain roughly the same as it was before the treatment. You will likely still need to wear glasses or specialised contact lenses.
Is the CXL procedure painful?
The procedure itself is not painful because strong local anaesthetic eye drops are used to completely numb the surface of the eye. However, it is very common to experience moderate to significant discomfort, pain, light sensitivity, and a gritty sensation for the first 3 to 5 days following the procedure while the surface layer (epithelium) heals. Mr Okonkwo will provide specific guidance on pain management and prescribe appropriate drops to help keep you comfortable.
Can both eyes be treated on the same day?
While it is technically possible to treat both eyes on the same day, it is generally not recommended. Because the vision in the treated eye is often quite blurry during the initial healing phase (the first week), treating one eye at a time ensures that you maintain functional vision in your untreated eye to help you manage daily tasks. The second eye is usually treated a few weeks or months later.
How do I know if my keratoconus is progressing?
Keratoconus progression is typically identified through a combination of changing symptoms—such as needing frequent updates to your glasses prescription or finding that contact lenses no longer fit comfortably—and objective clinical measurements. Mr Okonkwo uses advanced corneal tomography scans taken over several months to detect microscopic changes in the shape and thickness of your cornea, which confirm if the condition is actively worsening.
Are there any risks associated with CXL?
As with any surgical procedure, there are some risks involved, though serious complications are rare. Potential risks include a delay in the healing of the corneal surface, temporary or permanent corneal haze (cloudiness), infection, or a slight worsening of vision. Mr Okonkwo will discuss all potential risks and benefits with you in detail during your consultation so you can make a fully informed decision.
Quick Info
Duration
The entire clinical appointment may take up to two hours, with the actual active CXL procedure taking approximately 30 to 60 minutes per eye.
Recovery
Initial healing of the surface layer takes 3 to 5 days, during which time the eye may feel gritty or uncomfortable. Vision typically fluctuates before stabilising over several weeks to months.
Specialist Care
All treatment is strictly Consultant-led by a dual fellowship-trained corneal specialist, ensuring expert care at every stage.
Ready to Get Started?
Book a consultation to discuss your symptoms and treatment options.
Ready to Discuss Your Vision?
If you have been diagnosed with keratoconus or notice your vision continually changing, early expert assessment is crucial. Book a consultation to explore your treatment options and discuss how Corneal Collagen Cross-Linking can help protect your sight.